Clinical Trials in Poland

Active recruiting clinical trials with sites in Poland. Select a condition below to see detailed trial listings.

Total Trials: 90 // Recruiting: 90 // Updated: Daily

Poland currently has 90 clinical trials with at least one registered site in the country, of which 90 are actively recruiting participants. The most studied conditions at Poland sites are Safety Issues, Efficacy, Self, Systemic Lupus Erythematosus, reflecting where local investigators and sponsors are concentrating enrolment.

Studies are led by sponsors including Medical University of Warsaw, Poznan University of Medical Sciences, Medical University of Gdansk. By stage, active Poland trials break down as Phase 1 (4), Phase 2 (15), Phase 3 (12), Phase 4 (5). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.

Top Conditions in Poland

Safety Issues 2 Efficacy, Self 2 Systemic Lupus Erythematosus 2 Hip Osteoarthritis 2 Heart Failure 2 Prostate Cancer 2 Stereotactic Body Radiation Therapy (SBRT) 2 Dose Escalation: Solid Tumors 2 Total Knee Arthroplasty (TKA) 2 Local Recurrence of Malignant Tumor of Prostate 1 Radiotherapy 1 SAPHO Syndrome 1 Nausea and Vomiting Chemotherapy-Induced 1 Nausea Post Chemotherapy 1 Depressive Disorder 1 Histiocytosis 1 Peri-Prosthetic Joint Infection 1 Congenital Heart Defect 1 Cardiac Function 1 Arthropathy of Hip 1

All Countries → All Trials →

Other Countries in This Region

🇬🇷Greece 🇩🇪Germany 🇫🇷France 🇮🇹Italy 🇪🇸Spain 🇬🇧United Kingdom 🇳🇱Netherlands 🇧🇪Belgium 🇸🇪Sweden 🇦🇹Austria

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology